美国人口中代谢性肥胖现象和前列腺癌之间的关联:一个横截面研究
Xuefeng Lu1,2, Yanyan Wang3,4, Zhichang Jin1,2
1Department of Urology, Ningbo Urology & Nephrology Hospital, Ningbo, China.
Translational andrology and urology
|November 13, 2025
概括
代谢异常,不仅仅是肥胖,在50-64岁的男性中增加前列腺癌的风险. 不健康的代谢表型与更高的患病率有关,特别是高血糖和高血压.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 代谢性肥胖现象型是各种癌症的已知的危险因素.
- 前列腺癌 (PCa) 是老年男性的重大健康问题.
研究的目的:
- 调查代谢性肥胖表型与前列腺癌 (PCa) 患病率之间的关联.
- 根据代谢健康和肥胖状况分析50岁及以上美国男性的PCa风险.
主要方法:
- 国家健康和营养检查调查 (NHANES) 数据 (1999-2018) 的横截面分析.
- 将参与者分为四组:代谢健康的非肥胖者 (MHNO),代谢健康的肥胖者 (MHO),代谢不健康的非肥胖者 (MUNO) 和代谢不健康的肥胖者 (MUO).
- 按年龄加权的多变量逻辑回归和子组分析.
主要成果:
- 总体而言,肥胖和非肥胖群体之间的PCa患病率没有显著差异.
- 在50-64岁的男性中,高血糖和高血压等代谢异常与PCa患病率增加有很强的相关性.
- 代谢不健康的非肥胖 (MUNO) 和代谢不健康的肥胖 (MUO) 现型与较年轻年龄组中较高的PCa患病率显著相关.
结论:
- 在确定PCa患病率方面,代谢异常比单独的肥胖更为关键.
- 代谢表型和PCa之间的关联取决于年龄,主要影响50-64岁的男性.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
163
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K


